---
title: "Cencora, Inc. (COR.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/COR.US.md"
symbol: "COR.US"
name: "Cencora, Inc."
industry: "Health Care Distributors"
datetime: "2026-05-19T23:56:22.854Z"
locales:
  - [en](https://longbridge.com/en/quote/COR.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/COR.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/COR.US.md)
---

# Cencora, Inc. (COR.US)

## Company Overview

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Exchange | US Market |
| Website | [www.cencora.com](https://www.cencora.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:13.000Z

**Overall: C (0.41)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 4 / 16 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 5.95% |  |
| Net Profit YoY | 50.51% |  |
| P/B Ratio | 14.99 |  |
| Dividend Ratio | 0.90% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 50941749695.34 |  |
| Revenue | 328680018000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 115.58% | A |
| Profit Margin | 0.78% | C |
| Gross Margin | 4.56% | E |
| Revenue YoY | 5.95% | C |
| Net Profit YoY | 50.51% | B |
| Total Assets YoY | 14.69% | B |
| Net Assets YoY | 203.86% | A |
| Cash Flow Margin | 89.31% | C |
| OCF YoY | 5.95% | C |
| Turnover | 4.30 | A |
| Gearing Ratio | 95.61% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Cencora, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "5.95%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "50.51%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "14.99",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.90%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "50941749695.34",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "328680018000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "115.58%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "0.78%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "4.56%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "5.95%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "50.51%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "14.69%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "203.86%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "89.31%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "5.95%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "4.30",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "95.61%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 19.99 | 2/16 | 43.17 | 35.21 | 31.74 |
| PB | 14.99 | 8/16 | 54.85 | 37.03 | 30.41 |
| PS (TTM) | 0.15 | 2/16 | 0.21 | 0.19 | 0.18 |
| Dividend Yield | 0.90% | 2/16 | 0.74% | 0.71% | 0.64% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Henry Schein (HSIC.US) | B | C | A | D | B | B |
| 02 | ZeroStack (ZSTK.US) | E | B | A | A | B | B |
| 03 | McKesson (MCK.US) | E | B | A | E | B | C |
| 04 | Cencora (COR.US) | B | B | A | E | C | C |
| 05 | Cardinal Health (CAH.US) | E | C | A | E | B | C |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-11T04:00:00.000Z

Total Analysts: **14**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 8 | 57% |
| Overweight | 4 | 29% |
| Hold | 2 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 266.17 |
| Highest Target | 447.00 |
| Lowest Target | 340.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/COR.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/COR.US/norm.md)
- [Related News](https://longbridge.com/en/quote/COR.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/COR.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**